BetterLife Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 9, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022	Jan '21 Jan 31, 2021	2020 - 2016
Market Capitalization	10	11	6	10	14	55	Upgrade
Market Cap Growth	-12.53%	77.29%	-35.21%	-26.56%	-75.00%	197.60%	Upgrade
Enterprise Value	12	15	8	13	12	57	Upgrade
Last Close Price	0.06	0.09	0.06	0.11	0.16	1.06	Upgrade
PB Ratio	-2.18	-2.26	-1.13	-1.77	-4.47	-15.11	Upgrade
Debt / Equity Ratio	-0.12	-0.18	-0.07	-0.02	-0.08	-0.11	Upgrade
Net Debt / Equity Ratio	-0.12	-0.18	-0.07	-0.02	-0.04	-0.07	Upgrade
Net Debt / EBITDA Ratio	-	-	-0.16	-0.02	-0.01	-0.04	Upgrade
Net Debt / FCF Ratio	-3.43	-0.65	-0.21	-0.12	-0.01	-0.05	Upgrade
Quick Ratio	0.00	0.00	0.01	0.00	0.12	0.12	Upgrade
Current Ratio	0.05	0.03	0.04	0.01	0.28	0.23	Upgrade
Return on Assets (ROA)	-445.30%	-1074.42%	-1004.42%	-936.16%	-493.00%	-103.39%	Upgrade
Return on Capital Employed (ROCE)	33.00%	64.60%	45.70%	130.90%	334.40%	177.50%	Upgrade
Earnings Yield	-13.78%	-21.15%	-33.29%	-67.53%	-70.08%	-52.15%	Upgrade
FCF Yield	-	-12.15%	-28.49%	-11.26%	-64.57%	-10.29%	Upgrade
Buyback Yield / Dilution	-16.79%	-13.34%	-26.25%	-14.70%	-179.24%	-79.75%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.